Evidence map›Paper›PMID 20631574›Full record

ArticleJournal of clinical psychopharmacology2010

Reduced cannabis use after low-dose naltrexone addition to opioid detoxification.

Paolo Mannelli, Kathi Peindl, Ashwin A Patkar, Li-Tzy Wu, Chi-Un Pae, David A Gorelick

Abstract readLetter
In one paragraph

Article in Journal of clinical psychopharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Opioid antagonists with minimal sedation for opioid withdrawal.The Cochrane database of systematic reviews · 2017
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Paolo Mannelli
Kathi Peindl
Ashwin A Patkar
Li-Tzy Wu
Chi-Un Pae
David A Gorelick

Funding

Southern Consortium Node of the Clinical Trials NetworkU10DA013727 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2000 to 2015
$34.4M
Place of low-dose naltrexone in opiate detoxificationR21DA015469 · NIDA · THOMAS JEFFERSON UNIVERSITY · PI MANNELLI, PAOLO · 2003 to 2005
$557k
Epdemiology of Non-Medical Prescription Anagesic UseR01DA019901 · NIDA · DUKE UNIVERSITY · PI WU, LI-TZY · 2007 to 2009
$416k
Intramural NIH HHSNIDA NIH HHS 01DA019901NIDA NIH HHS DA15469NIDA NIH HHS R01 DA019901NIDA NIH HHS R21 DA015469NIDA NIH HHS U10 DA013727
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dose-Response Relationship, DrugFollow-Up StudiesHumansLogistic ModelsMarijuana AbuseNaltrexoneNarcotic AntagonistsOpioid-Related DisordersRandomized Controlled Trials as TopicNaltrexoneNarcotic Antagonists

Identifiers

PMID20631574
PMCPMC3091262

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.